Skip to main content
. 2020 Apr;21(4):935–941. doi: 10.31557/APJCP.2020.21.4.935

Table 1.

Formulations of ALNPs and Blank NPs

Formulation Atractylodin (mg) Acetone (mL) 12,000 MW PLGA (mg) 48,000 MW PLGA (mg) 1% Poloxamer 407 (mL)
ALNPs-1 1 1.5 22.5 - 15
ALNPs-2 1 1.5 - 22.5 15
Blank NPs-1 - 1.5 22.5 - 15
Blank NPs-2 - 1.5 - 22.5 15